SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Harvard Bioscience Inc – ‘S-4’ on 8/29/02 – EX-8.1

On:  Thursday, 8/29/02, at 3:58pm ET   ·   Accession #:  912057-2-34029   ·   File #:  333-98927

Previous ‘S-4’:  None   ·   Next & Latest:  ‘S-4/A’ on 9/17/02

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/29/02  Harvard Bioscience Inc            S-4                    6:1.9M                                   Merrill Corp/FA

Registration of Securities Issued in a Business-Combination Transaction   —   Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4         Registration of Securities Issued in a              HTML   1.99M 
                          Business-Combination Transaction                       
 2: EX-5.1      Opinion re: Legality                                   2     11K 
 3: EX-8.1      Opinion re: Tax Matters                                2     12K 
 4: EX-23.1     Consent of Experts or Counsel                          1      7K 
 5: EX-99.2     Miscellaneous Exhibit                                  2      9K 
 6: EX-99.3     Miscellaneous Exhibit                                  1      5K 


EX-8.1   —   Opinion re: Tax Matters

EX-8.11st Page of 2TOCTopPreviousNextBottomJust 1st
 

Exhibit 8.1 [Letterhead of Jaffe, Raitt, Heuer & Weiss, P.C.] August 23, 2002 Genomic Solutions Inc. 4355 Varsity Drive, Suite E Ann Arbor, Michigan 48108 Ladies and Gentlemen: We have acted as counsel to Genomic Solutions Inc. ("GSI") in connection with the contemplated merger (the "Merger") of GSI with and into HAG Acq. Corp. ("Sub"), a Delaware corporation and wholly-owned subsidiary of Harvard Bioscience, Inc., a Delaware corporation ("HBIO"), pursuant to an Agreement and Plan of Merger dated July 17, 2002 (the "Merger Agreement"), by and among GSI, Sub and HBIO. All capitalized terms used herein, unless otherwise specified, have the meanings assigned to them in the Merger Agreement. This opinion is being delivered to you in satisfaction of Section 8.2(e) of the Merger Agreement. In rendering our opinion, we have examined and relied upon the accuracy and completeness of the facts, information, covenants and representations contained in the Merger Agreement and such other documents and corporate records as we have deemed necessary or appropriate for purposes of this opinion. In addition, we have relied upon certain statements, representations and agreements made by GSI and HBIO, including representations set forth in the Officer's Certificates of GSI and HBIO that were provided to us (the "Officers' Certificates"). Our opinion is conditioned on, among other things, the initial and continuing accuracy of the facts, information, covenants and representations set forth in the documents referred to above and the statements, representations and agreements made by GSI, HBIO and others, including those set forth in the Officers' Certificates. We have no reason to believe that such facts, information, covenants and representations are not true, but have not attempted to verify them independently and expressly disclaim an opinion as to their validity and accuracy. In our examination, in addition to the foregoing, we have assumed (without any independent investigation) that: 1. Original documents (including signatures thereto) are authentic, documents submitted to us as certified, photostatic or facsimile copies conform to the original documents, and there has been due execution and delivery of all documents where due execution and delivery are prerequisites to the effectiveness thereof.
EX-8.1Last Page of 2TOC1stPreviousNextBottomJust 2nd
Genomic Solutions Inc. August 23, 2002 Page 2 2. The Merger Agreement and all other documents and instruments referred to therein are valid and binding in accordance with their terms. 3. The Transactions contemplated by the Merger Agreement will be consummated in accordance with such agreements and all covenants contained in the Merger Agreement (including exhibits thereto) will be performed without waiver or breach of any material provision thereof. 4. The matters set forth in the Officers' Certificates are true and will remain true at the Effective Time. 5. The Certificate of Merger, which incorporates the terms of the Merger, will be filed in the appropriate office in the State of Delaware. The opinion expressed in this letter is based on the provisions of the Internal Revenue Code of 1986, as amended, Treasury regulations promulgated thereunder, and administrative and judicial interpretations thereof, all as in effect as of the date hereof. All of the foregoing are subject to change, perhaps with retroactive effect; any such change may require modification of the opinion rendered herein. No ruling from the Internal Revenue Service (the "IRS") has been or will be sought on any aspect of the Merger, and there can be no assurance that the IRS will not take a contrary view. Although our opinion expressed in this letter represents our best judgment as to such matter, our opinion has no binding effect on the IRS or the courts. Based upon and subject to the foregoing, and subject to the qualifications set forth herein, it is our opinion that, for federal income tax purposes the Merger will constitute a "reorganization" within the meaning of Section 368(a) of the Code. We express no opinions as to matters of law other than the matters of federal income tax law specifically addressed hereby. We are furnishing this opinion to you solely for the purpose of its satisfying the condition to Closing described in Section 8.2(e) of the Merger Agreement. It may not be relied upon for any other purpose or by any other person or entity, and may not be made available to any other person or entity without our prior written consent. We disclaim any obligation to update this opinion letter for events, including changes of law, which occur or come to our attention after the date hereof. We hereby consent to the filing of this opinion as an Exhibit to the Form S-4. We also consent to the reference to our firm name wherever appearing in the Form S-4 with respect to the discussion of the material federal income tax consequences of the Merger, including the Proxy Statement constituting a part thereof, and any amendment thereto. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we thereby admit that we are experts with respect to any part of such Form S-4 within the meaning of the term "experts" as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder. Very truly yours, JAFFE, RAITT, HEUER & WEISS, P.C. Professional Corporation /s/ William E. Sider William E. Sider

Dates Referenced Herein

Referenced-On Page
This ‘S-4’ Filing    Date First  Last      Other Filings
Filed on:8/29/02None on these Dates
8/23/0212
7/17/021
 List all Filings 
Top
Filing Submission 0000912057-02-034029   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 10:35:35.1pm ET